VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a Canadian clinical stage ...
You may be popping cough drops like it’s your job, or maybe you’ve just accepted that the symptom is your way of life for now ...
MANCHESTER, England & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, announced that it will present ...
A dry cough that lingers without fever or mucus may be linked to poor air quality. Doctors explain how pollution irritates ...
Having a cough is a clear sign that something just isn’t right in your lungs. It can be easy to chalk it up to something like a lingering cold, your partner’s smoking habit, or another obvious culprit ...
Geneva, Switzerland, June 5, 2025-Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for ...
The other day, a student enrolled in the medical ethics class I teach stopped by after class and expressed concern about a very serious problem that is being exacerbated in the wake of the outbreak of ...
VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB ...
Title: Results of RELIEF, a Phase 2a study with BLU-5937 in Refractory Chronic Cough Details: The presentation will highlight nominal effect size and baseline characteristics of the ITT population in ...
Having a cough is a clear sign that something just isn’t right in your lungs. It can be easy to chalk it up to something like a lingering cold, your partner’s smoking habit, or another obvious culprit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback